SCHEMBL7366506

SCHEMBL7366506

CNC(=O)C(=O)CCCCCCNC(=O)Nc1cc(OC)cc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
PKM P14618 1/20 0.47
HSD17B10 Q99714 1/20 0.47
HDAC1 Q13547 7/20 0.46
HDAC2 Q92769 7/20 0.46
LMNA P02545 1/20 0.46
CNR1 P21554 1/20 0.44
HDAC3 O15379 3/20 0.44
HDAC4 P56524 3/20 0.44
HDAC7 Q8WUI4 3/20 0.44
HDAC10 Q969S8 3/20 0.44
HDAC11 Q96DB2 3/20 0.44
HDAC8 Q9BY41 3/20 0.44
HDAC6 Q9UBN7 3/20 0.44
HDAC9 Q9UKV0 3/20 0.44
HDAC5 Q9UQL6 3/20 0.44
POLB P06746 1/20 0.43
EPHX1 P07099 2/20 0.43
MARS1 P56192 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7368829 0.88 PKM (0.64) KMT2APKMHSD17B10HDAC1HDAC2
SCHEMBL7370963 0.88 L3MBTL1 (0.52) HDAC1HDAC2LMNACNR1HDAC3
SCHEMBL7393732 0.84 PKM (0.58) KMT2APKMHSD17B10HDAC1HDAC2
SCHEMBL7399200 0.82 ALDH1A1 (0.47) HDAC1HDAC2LMNACNR1HDAC3
SCHEMBL14338662 0.81 EPHX1 (0.60) KMT2APKMHSD17B10POLBEPHX1
SCHEMBL14338652 0.81 EPHX1 (0.60) KMT2APKMHSD17B10POLBEPHX1
SCHEMBL7372586 0.79 HDAC1 (0.76) KMT2APKMHSD17B10HDAC1HDAC2
SCHEMBL7373503 0.79 HDAC1 (0.70) HDAC1HDAC2LMNAHDAC3HDAC4
SCHEMBL7375644 0.78 HDAC1 (0.74) HDAC1HDAC2LMNAHDAC3HDAC4
SCHEMBL7371657 0.78 HDAC1 (0.51) KMT2APKMHDAC1HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 KMT2A 86/4885PKM 1131/4885HSD17B10 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.